1. CD55 is a HIF-2α marker with anti-adhesive and pro-invading properties in neuroblastoma
    F Cimmino et al, 2016, Oncogenesis CrossRef
  2. The imbalance in the complement system and its possible physiological mechanisms in patients with lung cancer
    Ping Zhao et al, 2019, BMC Cancer CrossRef
  3. Synthesis and Enhanced Cellular Uptake In Vitro of Anti-HER2 Multifunctional Gold Nanoparticles
    null Cruz et al, 2019, Cancers CrossRef
  4. Bispecific Complement Engagers for Targeted Complement Activation
    Dennis V. Pedersen et al, 2023, The Journal of Immunology CrossRef
  5. Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for Intervention
    Zvi Fishelson et al, 2019, Frontiers in Immunology CrossRef
  6. Oncolytic viral vectors in the era of diversified cancer therapy: from preclinical to clinical
    Chao Tang et al, 2022, Clinical and Translational Oncology CrossRef
  7. Heterogeneity and Functions of Tumor-Infiltrating Antibody Secreting Cells: Lessons from Breast, Ovarian, and Other Solid Cancers
    Yasmine Lounici et al, 2022, Cancers CrossRef
  8. Applicability of Traditional In Vitro Toxicity Tests for Assessing Adverse Effects of Monoclonal Antibodies: A Case Study of Rituximab and Trastuzumab
    Arathi Kizhedath et al, 2018, Antibodies CrossRef
  9. Improvement of Antibody Activity by Controlling Its Dynamics Using the Glycan–Lectin Interaction
    Yoshiyuki Manabe et al, 2023, Angewandte Chemie CrossRef
  10. Hypoxia effects on oncolytic virotherapy in Cancer: Friend or Foe?
    Maryam Sadri et al, 2023, International Immunopharmacology CrossRef
  11. Immuno-pharmacodynamics for evaluating mechanism of action and developing immunotherapy combinations
    Ralph E. Parchment et al, 2016, Seminars in Oncology CrossRef
  12. New perspectives on complement mediated immunotherapy
    Grzegorz Stasiłojć et al, 2016, Cancer Treatment Reviews CrossRef
  13. Formulation of patient dose of [177Lu]Lu‐Trastuzumab using in‐house developed freeze‐dried kit: A path forward for clinical translation
    Jeyachitra Amirdhanayagam et al, 2024, Journal of Labelled Compounds and Radiopharmaceuticals CrossRef
  14. Improvement of Antibody Activity by Controlling Its Dynamics Using the Glycan–Lectin Interaction
    Yoshiyuki Manabe et al, 2023, Angewandte Chemie International Edition CrossRef
  15. Membrane-Bound Complement Regulatory Proteins in Breast Cancer: Are They Best Therapeutic Targets?
    Sofia Álvarez-Lorenzo et al, 2023, Breast Cancer Updates CrossRef
  16. Complement system's role in cancer and its therapeutic potential in ovarian cancer
    H. Bareke et al, 2018, Scandinavian Journal of Immunology CrossRef
  17. CD55 and CD59 expression protects HER2-overexpressing breast cancer cells from trastuzumab-induced complement-dependent cytotoxicity
    Yu Wang et al, 2017, Oncology Letters CrossRef
  18. High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer
    Xiaoyong Fu et al, 2023, Cell Reports CrossRef
  19. Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosis
    Li-Chung Tsao et al, 2022, JCI Insight CrossRef
  20. Effect of IL-6 and IL-8 on the expression of the complement activation inhibitors MAC-inhibitory protein and decay-accelerating factor in ovarian cancer A2780 cells
    Lucyna Kapka-Skrzypczak et al, 2016, Oncology Letters CrossRef

  21. Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy


    Yao Chen et al, 2020, International Journal of Nanomedicine CrossRef
  22. The membrane complement regulatory protein CD59 promotes tumor growth and predicts poor prognosis in breast cancer
    QIANWEN OUYANG et al, 2016, International Journal of Oncology CrossRef
  23. Downregulation of complement factor H attenuates the stemness of MDA‑MB‑231 breast cancer cells via modulation of the ERK and p38 signaling pathways
    Soon Park et al, 2023, Oncology Letters CrossRef
  24. FHR4‐based immunoconjugates direct complement‐dependent cytotoxicity and phagocytosis towards HER2‐positive cancer cells
    Carole Seguin‐Devaux et al, 2019, Molecular Oncology CrossRef
  25. The Role of Complement in the Mechanism of Action of Therapeutic Anti-Cancer mAbs
    Josée Golay et al, 2020, Antibodies CrossRef